Patient-Reported Outcomes After Chemoradiation in Patients With Anal Cancer: A Qualitative Analysis
Author:
Publisher
Elsevier BV
Subject
Radiology, Nuclear Medicine and imaging,Oncology
Reference24 articles.
1. Long term outcomes of NRG Oncology/RTOG 0529: A phase II evaluation of dose-painted intensity modulated radiation therapy (DP-IMRT) in combination with 5-fluorouracil and mitomycin-c for the reduction of acute morbidity in anal canal cancer;Kachnic;Int J Radiat Oncol Biol Phys,2022
2. Fluorouracil, mitomycin, and radiotherapy vs fluorouracil, cisplatin, and radiotherapy for carcinoma of the anal canal: A randomized controlled trial;Ajani;JAMA,2008
3. Epidermoid anal cancer: Results from the UKCCCR randomised trial of radiotherapy alone versus radiotherapy, 5-fluorouracil, and mitomycin. UKCCCR Anal Cancer Trial Working Party. UK Co-ordinating Committee on Cancer Research;Lancet,1996
4. Mitomycin or cisplatin chemoradiation with or without maintenance chemotherapy for treatment of squamous-cell carcinoma of the anus (ACT II): A randomised, phase 3, open-label, 2 × 2 factorial trial;James;Lancet Oncol,2013
5. Late gastrointestinal toxicity after radiotherapy for anal cancer: A systematic literature review;Pan;Acta Oncol,2018
Cited by 4 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Treatment of stage I-III squamous cell anal cancer: a comparative effectiveness systematic review;JNCI: Journal of the National Cancer Institute;2024-08-20
2. Pleasurable and problematic receptive anal intercourse and diseases of the colon, rectum and anus;Nature Reviews Gastroenterology & Hepatology;2024-05-19
3. Random Forest Modeling of Acute Toxicity in Anal Cancer: Effects of Peritoneal Cavity Contouring Approaches on Model Performance;International Journal of Radiation Oncology*Biology*Physics;2024-02
4. Long-Term Patient-Reported Quality of Life of Anal Cancer Survivors Treated With Intensity Modulated Radiation Therapy and Concurrent Chemotherapy: Results From a Prospective Phase II Trial;International Journal of Radiation Oncology*Biology*Physics;2023-10
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3